1. Home
  2. MLYS vs MSC Comparison

MLYS vs MSC Comparison

Compare MLYS & MSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • MSC
  • Stock Information
  • Founded
  • MLYS 2019
  • MSC 2000
  • Country
  • MLYS United States
  • MSC Hong Kong
  • Employees
  • MLYS N/A
  • MSC N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • MSC Hotels/Resorts
  • Sector
  • MLYS Health Care
  • MSC Consumer Discretionary
  • Exchange
  • MLYS Nasdaq
  • MSC Nasdaq
  • Market Cap
  • MLYS 893.0M
  • MSC 770.4M
  • IPO Year
  • MLYS 2023
  • MSC 2018
  • Fundamental
  • Price
  • MLYS $14.66
  • MSC $3.60
  • Analyst Decision
  • MLYS Strong Buy
  • MSC
  • Analyst Count
  • MLYS 3
  • MSC 0
  • Target Price
  • MLYS $27.00
  • MSC N/A
  • AVG Volume (30 Days)
  • MLYS 2.0M
  • MSC 9.2K
  • Earning Date
  • MLYS 05-08-2025
  • MSC 04-29-2025
  • Dividend Yield
  • MLYS N/A
  • MSC N/A
  • EPS Growth
  • MLYS N/A
  • MSC N/A
  • EPS
  • MLYS N/A
  • MSC N/A
  • Revenue
  • MLYS N/A
  • MSC $639,145,000.00
  • Revenue This Year
  • MLYS N/A
  • MSC $8.92
  • Revenue Next Year
  • MLYS N/A
  • MSC N/A
  • P/E Ratio
  • MLYS N/A
  • MSC N/A
  • Revenue Growth
  • MLYS N/A
  • MSC 43.45
  • 52 Week Low
  • MLYS $8.24
  • MSC $2.30
  • 52 Week High
  • MLYS $18.38
  • MSC $9.30
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 56.01
  • MSC 45.86
  • Support Level
  • MLYS $16.15
  • MSC $3.48
  • Resistance Level
  • MLYS $17.21
  • MSC $3.77
  • Average True Range (ATR)
  • MLYS 1.30
  • MSC 0.11
  • MACD
  • MLYS -0.03
  • MSC 0.02
  • Stochastic Oscillator
  • MLYS 36.19
  • MSC 18.21

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About MSC Studio City International Holdings Limited

Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including 15 tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.

Share on Social Networks: